Clinical trial

Sotagliflozin in Heart Failure With Preserved Ejection Fraction (HFpEF) Patients

NCT05562063

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-10-26

PhasePHASE4

Study timeline

Study start (actual)2022-10-26Date precision: day

Registry last updated2026-06-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failure With Preserved Ejection Fractionunresolved

Interventions

SotagliflozinDRUG · verified · RxNorm: sotagliflozin

PlaceboDRUG

Sponsors & collaborators

Juan Badimonlead sponsor

Mapped research locations

New YorkNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05562063 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.